Gata6 in pluripotent stem cells enhance the potential to differentiate into cardiomyocytes
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Pluripotent stem cell (PSC) variations can cause significant differences in the efficiency of cardiac differentiation. This process is unpredictable, as there is not an adequate indicator at the undifferentiated stage of the PSCs. We compared global gene expression profiles of two PSCs showing significant differences in cardiac differentiation potential. We identified 12 up-regulated genes related to heart development, and we found that 4 genes interacted with multiple genes. Among these genes, Gata6 is the only gene that was significantly induced at the early stage of differentiation of PSCs to cardiomyocytes. Gata6 knock-down in PSCs decreased the efficiency of cardiomyocyte production. In addition, we analyzed 6 mESC lines and 3 iPSC lines and confirmed that a positive correlation exists between Gata6 levels and efficiency of differentiation into cardiomyocytes. In conclusion, Gata6 could be utilized as a biomarker to select the best PSC lines to produce PSC-derived cardiomyocytes for therapeutic purposes.
Abstract
Pluripotent stem cell (PSC) variations can cause significant differences in the efficiency of cardiac differentiation. This process is unpredictable, as there is not an adequate indicator at the undifferentiated stage of the PSCs. We compared global gene expression profiles of two PSCs showing significant differences in cardiac differentiation potential. We identified 12 up-regulated genes related to heart development, and we found that 4 genes interacted with multiple genes. Among these genes, Gata6 is the only gene that was significantly induced at the early stage of differentiation of PSCs to cardiomyocytes. Gata6 knock-down in PSCs decreased the efficiency of cardiomyocyte production. In addition, we analyzed 6 mESC lines and 3 iPSC lines and confirmed that a positive correlation exists between Gata6 levels and efficiency of differentiation into cardiomyocytes. In conclusion, Gata6 could be utilized as a biomarker to select the best PSC lines to produce PSC-derived cardiomyocytes for therapeutic purposes.
참고문헌 (23)
- 김평환, "Myocardial tissue engineering using electrospun nanofiber composites", BMB Reports, 49(1), pp.26~36 (2016), 생화학분자생물학회
- Tongers J, "Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challenges", Eur Heart J, 32, pp.1197~1206 (2011)[DOI]
- Zhang J, "Functional cardiomyocytes derived from human induced pluripotent stem cells", Circ Res, 104, pp.e30~e41 (2009)[DOI]
- Narazaki G, "Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells", Circulation, 118, pp.498~506 (2008)[DOI]
- Nelson TJ, "Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells", Circulation, 120, pp.408~416 (2009)[DOI]
- Kaichi S, "Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice", Cardiovasc Res, 88, pp.314~323 (2010)[DOI]
- Streckfuss-Bomeke K, "Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts", Eur Heart J, 34, pp.2618~2629 (2013)
- Burridge PW, "Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming", Cell Stem Cell, 10, pp.16~28 (2012)[DOI]
- Cho HJ, "Induction of pluripotent stem cells from adult somatic cells by protein-based reprogramming without genetic manipulation", Blood, 116, pp.386~395 (2010)[DOI]
- Di Giorgio FP, "Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation", Cell Stem Cell, 3, pp.637~648 (2008)[DOI]
- Osafune K, "Marked differences in differentiation propensity among human embryonic stem cell lines", Nat Biotechnol, 26, pp.313~315 (2008)[DOI]
- Chin MH, "Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures", Cell Stem Cell, 5, pp.111~123 (2009)[DOI]
- Narsinh KH, "Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells", J Clin Invest, 121, pp.1217~1221 (2011)[DOI]
- Doi A, "Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells, and fibroblasts", Nat Genet, 41, pp.1350~1353 (2009)[DOI]
- Hu BY, "Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency", Proc Natl Acad Sci U S A, 107, pp.4335~4340 (2010)[DOI]
- Morrisey EE, "GATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryo", Genes Dev, 12, pp.3579~3590 (1998)[DOI]
- Lepore JJ, "GATA-6 regulates semaphorin 3C and is required in cardiac neural crest for cardiovascular morphogenesis", J Clin Invest, 116, pp.929~939 (2006)[DOI]
- Xin M, "A threshold of GATA4 and GATA6 expression is required for cardiovascular development", Proc Natl Acad Sci U S A, 103, pp.11189~11194 (2006)[DOI]
- Zhao R, "Loss of both GATA4 and GATA6 blocks cardiac myocyte differentiation and results in acardia in mice", Dev Biol, 317, pp.614~619 (2008)[DOI]
- Turbendian HK, "GATA factors efficiently direct cardiac fate from embryonic stem cells", Development, 140, pp.1639~1644 (2013)[DOI]
- Maltsev VA, "Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents", Circ Res, 75, pp.233~244 (1994)[DOI]
- 김진옥, "miR-185 inhibits endoplasmic reticulum stress-induced apoptosis by targeting Na+", H+ exchanger-1 in the heart, 2016, pp.49(4), 208~213[DOI]
- Rubinson DA, "A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference", Nat Genet, 33, pp.401~406 (2003)[DOI]